Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | MIG | 43.0 | 43 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 4 | MIG | 50.0 | 41 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | MIG | 106.0 | 49 | |
N2645 | IL-1 alpha | 100 | ng/mL | 4 | MIG | 101.0 | 49 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | MIG | 80.0 | 65 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 4 | MIG | 68.0 | 59 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | MIG | 21.0 | 54 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | MIG | 40.0 | 57 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | MIG | 56.0 | 68 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | MIG | 68.0 | 55 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | MIG | 29.5 | 70 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | MIG | 121.0 | 59 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | MIG | 62.0 | 47 | |
RA2159 | TNF-a | 100 | ng/mL | 4 | MIG | 48.0 | 48 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | MIG | 106.0 | 52 | |
N2645 | TNF-a | 100 | ng/mL | 4 | MIG | 96.0 | 39 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | MIG | 159.0 | 49 | |
RA2708 | TNF-a | 100 | ng/mL | 4 | MIG | 156.0 | 51 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 4 | MIG | 20.5 | 46 | ||||
RA2159 | IKK16 | 2.0 | uM | 4 | MIG | 24.0 | 41 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 4 | MIG | 16.0 | 52 | ||||
N2645 | IKK16 | 2.0 | uM | 4 | MIG | 16.0 | 62 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 4 | MIG | 25.0 | 51 | ||||
RA2708 | IKK16 | 2.0 | uM | 4 | MIG | 30.0 | 47 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 4 | MIG | 24.0 | 48 |